JP2004513631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004513631A5 JP2004513631A5 JP2002542049A JP2002542049A JP2004513631A5 JP 2004513631 A5 JP2004513631 A5 JP 2004513631A5 JP 2002542049 A JP2002542049 A JP 2002542049A JP 2002542049 A JP2002542049 A JP 2002542049A JP 2004513631 A5 JP2004513631 A5 JP 2004513631A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- tssk
- amino acid
- acid sequence
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 238000006467 substitution reaction Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims 8
- 108091000080 Phosphotransferase Proteins 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 5
- 102000020233 phosphotransferase Human genes 0.000 claims 5
- 239000005557 antagonist Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 239000000758 substrate Substances 0.000 claims 3
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 238000000021 kinase assay Methods 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- ZKHQWZAMYRWXGA-KNYAHOBESA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] dihydroxyphosphoryl hydrogen phosphate Chemical group C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)O[32P](O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KNYAHOBESA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24693900P | 2000-11-09 | 2000-11-09 | |
| US26492101P | 2001-01-30 | 2001-01-30 | |
| PCT/US2001/046803 WO2002038732A2 (en) | 2000-11-09 | 2001-11-09 | Human testis specific serine/threonine kinase |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003184906A Division JP2004135653A (ja) | 2000-11-09 | 2003-06-27 | ヒト精巣特異的セリン／スレオニンキナーゼ |
| JP2009035474A Division JP2009148281A (ja) | 2000-11-09 | 2009-02-18 | ヒト精巣特異的セリン／スレオニンキナーゼ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004513631A JP2004513631A (ja) | 2004-05-13 |
| JP2004513631A5 true JP2004513631A5 (enExample) | 2005-04-21 |
Family
ID=26938336
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002542049A Pending JP2004513631A (ja) | 2000-11-09 | 2001-11-09 | ヒト精巣特異的セリン／スレオニンキナーゼ |
| JP2003184906A Withdrawn JP2004135653A (ja) | 2000-11-09 | 2003-06-27 | ヒト精巣特異的セリン／スレオニンキナーゼ |
| JP2007174924A Pending JP2007306930A (ja) | 2000-11-09 | 2007-07-03 | ヒト精巣特異的セリン／スレオニンキナーゼ |
| JP2009035474A Pending JP2009148281A (ja) | 2000-11-09 | 2009-02-18 | ヒト精巣特異的セリン／スレオニンキナーゼ |
| JP2009216891A Pending JP2010029197A (ja) | 2000-11-09 | 2009-09-18 | ヒト精巣特異的セリン／スレオニンキナーゼ |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003184906A Withdrawn JP2004135653A (ja) | 2000-11-09 | 2003-06-27 | ヒト精巣特異的セリン／スレオニンキナーゼ |
| JP2007174924A Pending JP2007306930A (ja) | 2000-11-09 | 2007-07-03 | ヒト精巣特異的セリン／スレオニンキナーゼ |
| JP2009035474A Pending JP2009148281A (ja) | 2000-11-09 | 2009-02-18 | ヒト精巣特異的セリン／スレオニンキナーゼ |
| JP2009216891A Pending JP2010029197A (ja) | 2000-11-09 | 2009-09-18 | ヒト精巣特異的セリン／スレオニンキナーゼ |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7129057B2 (enExample) |
| EP (1) | EP1339866B1 (enExample) |
| JP (5) | JP2004513631A (enExample) |
| AT (2) | ATE477332T1 (enExample) |
| AU (4) | AU2002237699B9 (enExample) |
| DE (2) | DE60142804D1 (enExample) |
| IL (4) | IL155800A0 (enExample) |
| WO (1) | WO2002038732A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1278864A2 (en) * | 2000-05-12 | 2003-01-29 | MERCK PATENT GmbH | Serine-threonine kinase-3 |
| US20050032146A1 (en) * | 2003-08-07 | 2005-02-10 | Herr John C. | Tssk4: a human testis specific serine/threonine kinase |
| US20080274117A1 (en) * | 2004-09-30 | 2008-11-06 | Herr John C | Validation of Tssk Family Members and Tsks as Male Contraceptive Targets |
| JP2008067649A (ja) * | 2006-09-14 | 2008-03-27 | Osaka Univ | 妊孕性診断キット、変異検出方法、ポリヌクレオチド、及びポリペプチド |
| CN115976033B (zh) * | 2022-12-14 | 2024-05-17 | 西南大学 | 瓜实蝇tssk1和tssk3基因及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003501038A (ja) * | 1999-05-28 | 2003-01-14 | スージェン・インコーポレーテッド | 蛋白質キナーゼ |
| AU2292301A (en) * | 1999-12-23 | 2001-07-03 | Incyte Genomics, Inc. | Human kinases |
| US20040048249A1 (en) * | 2000-01-21 | 2004-03-11 | Tang Y. Tom | Novel nucleic acids and secreted polypeptides |
| CA2399776A1 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| WO2001083768A2 (en) * | 2000-05-05 | 2001-11-08 | Merck Patent Gmbh | Serine-threonine kinase |
| US6482935B1 (en) * | 2000-05-24 | 2002-11-19 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002068649A2 (en) * | 2001-01-31 | 2002-09-06 | Curagen Corporation | Proteins and nucleic acids encoding same |
| US20030211093A1 (en) * | 2001-07-20 | 2003-11-13 | Henry Yue | Human kinases |
-
2001
- 2001-11-09 EP EP01986508A patent/EP1339866B1/en not_active Expired - Lifetime
- 2001-11-09 DE DE60142804T patent/DE60142804D1/de not_active Expired - Lifetime
- 2001-11-09 AT AT03018045T patent/ATE477332T1/de not_active IP Right Cessation
- 2001-11-09 IL IL15580001A patent/IL155800A0/xx unknown
- 2001-11-09 IL IL15580101A patent/IL155801A0/xx unknown
- 2001-11-09 AT AT01986508T patent/ATE479771T1/de not_active IP Right Cessation
- 2001-11-09 WO PCT/US2001/046803 patent/WO2002038732A2/en not_active Ceased
- 2001-11-09 AU AU2002237699A patent/AU2002237699B9/en not_active Ceased
- 2001-11-09 JP JP2002542049A patent/JP2004513631A/ja active Pending
- 2001-11-09 US US10/416,477 patent/US7129057B2/en not_active Expired - Lifetime
- 2001-11-09 DE DE60142984T patent/DE60142984D1/de not_active Expired - Lifetime
- 2001-11-09 AU AU3769902A patent/AU3769902A/xx active Pending
-
2003
- 2003-05-08 IL IL155801A patent/IL155801A/en not_active IP Right Cessation
- 2003-05-08 IL IL155800A patent/IL155800A/en not_active IP Right Cessation
- 2003-05-09 US US10/438,339 patent/US6946275B2/en not_active Expired - Lifetime
- 2003-05-20 AU AU2003204266A patent/AU2003204266B2/en not_active Ceased
- 2003-06-27 JP JP2003184906A patent/JP2004135653A/ja not_active Withdrawn
-
2006
- 2006-05-16 AU AU2006202059A patent/AU2006202059C1/en not_active Ceased
-
2007
- 2007-07-03 JP JP2007174924A patent/JP2007306930A/ja active Pending
-
2009
- 2009-02-18 JP JP2009035474A patent/JP2009148281A/ja active Pending
- 2009-09-18 JP JP2009216891A patent/JP2010029197A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Reinhard et al. | VASP interaction with vinculin: a recurring theme of interactions with proline‐rich motifs | |
| Fricker et al. | Cloning and sequence analysis of cDNA for bovine carboxypeptidase E | |
| Skidgel et al. | Cellular carboxypeptidases | |
| JP2005516072A5 (enExample) | ||
| US6280964B1 (en) | Binding sites for phosphotyrosine binding domains | |
| US11124540B2 (en) | Polypeptides for the treatment of diseases | |
| JP2010536759A5 (enExample) | ||
| Zetterqvist et al. | Substrate specificity of cyclic AMP-dependent protein kinase | |
| CA2445421A1 (en) | Von willebrand factor (vwf)-cleaving protease | |
| KR950703003A (ko) | 미토게네시스 및 모토게네시스의 펩타이드 억제제(peptide inhibitors of mitogenesis and motogenesis) | |
| JPH06507543A (ja) | ヒト血小板由来成長因子レセプターポリペプチドの細胞外領域ドメイン | |
| JP2004536614A5 (enExample) | ||
| CA2491320A1 (en) | Methods and compositions for modulating t helper (th) cell development and function | |
| JP7604368B2 (ja) | ストレス症候群、免疫反応症候群及び卒中症候群の処置のためのポリペプチド | |
| CA2221409A1 (en) | Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same | |
| JP2004513631A5 (enExample) | ||
| SK62997A3 (en) | Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof | |
| AU2001289034A1 (en) | Novel pdes and uses thereof | |
| Adams et al. | A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen‐activated protein kinase pathway to activate c‐Jun N‐terminal kinase and a functional AP‐1 containing c‐Jun and c‐Fos proteins in mouse NB2a cells | |
| Richter et al. | Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4 | |
| Schäfer et al. | Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity | |
| WO2004083241A2 (en) | Btc-interacting proteins and use thereof | |
| US6812017B2 (en) | Mammalian secreted group IIF phospholipase A2 | |
| US7276587B2 (en) | Antibodies to EGFH2 polypeptides | |
| US20030167129A1 (en) | Binding compounds and methods for identifying binding compounds |